Zuellig Pharma

ROCHE (MALAYSIA) SDN BHD

Featured products of Roche
tocilizumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
4 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
alectinib
Packing/Price
4 × 56's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
mycophenolate mofetil
Packing/Price
100's
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
mycophenolate mofetil
Packing/Price
50's
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
cobimetinib fumarate
Packing/Price
63's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EE02 - cobimetinib : Belongs to the class of mitogen-activated protein kinase (MEK) inhibitors. Used in the treatment of cancer.
pirfenidone
Packing/Price
270's
MIMS Class
Immunosuppressants
ATC Classification
L04AX05 - pirfenidone : Belongs to the class of other immunosuppressants.
obinutuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA03 - obinutuzumab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
rituximab
Packing/Price
2 × 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
rituximab
Packing/Price
(single-dose) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
pertuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD02 - pertuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
pertuzumab, trastuzumab
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XY02 - pertuzumab and trastuzumab : Belongs to the class of combinations of antineoplastic agents. Used in the treatment of cancer.
pertuzumab, trastuzumab
Packing/Price
10 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XY02 - pertuzumab and trastuzumab : Belongs to the class of combinations of antineoplastic agents. Used in the treatment of cancer.
polatuzumab vedotin
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
atezolizumab
Packing/Price
((single-use)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
atezolizumab
Packing/Price
(single-use) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
baloxavir marboxil
Packing/Price
4's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
baloxavir marboxil
Packing/Price
1's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
vemurafenib
Packing/Price
56's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EC01 - vemurafenib : Belongs to the class of B-Raf serine-threonine kinase (BRAF) inhibitors. Used in the treatment of cancer.
Distributed by Zuellig Pharma
tocilizumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
4 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
alectinib
Packing/Price
4 × 56's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
mycophenolate mofetil
Packing/Price
100's
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
mycophenolate mofetil
Packing/Price
50's
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
cobimetinib fumarate
Packing/Price
63's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EE02 - cobimetinib : Belongs to the class of mitogen-activated protein kinase (MEK) inhibitors. Used in the treatment of cancer.
pirfenidone
Packing/Price
270's
MIMS Class
Immunosuppressants
ATC Classification
L04AX05 - pirfenidone : Belongs to the class of other immunosuppressants.
obinutuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA03 - obinutuzumab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
rituximab
Packing/Price
2 × 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
rituximab
Packing/Price
(single-dose) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
pertuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD02 - pertuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
pertuzumab, trastuzumab
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XY02 - pertuzumab and trastuzumab : Belongs to the class of combinations of antineoplastic agents. Used in the treatment of cancer.
pertuzumab, trastuzumab
Packing/Price
10 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XY02 - pertuzumab and trastuzumab : Belongs to the class of combinations of antineoplastic agents. Used in the treatment of cancer.
polatuzumab vedotin
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
atezolizumab
Packing/Price
((single-use)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
atezolizumab
Packing/Price
(single-use) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
baloxavir marboxil
Packing/Price
4's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
baloxavir marboxil
Packing/Price
1's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
vemurafenib
Packing/Price
56's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EC01 - vemurafenib : Belongs to the class of B-Raf serine-threonine kinase (BRAF) inhibitors. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in